{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:35:34Z","timestamp":1761129334094},"reference-count":59,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2016.00672","type":"journal-article","created":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T09:02:06Z","timestamp":1462870926000},"update-policy":"http:\/\/dx.doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Increased Prevalence of Human Polyomavirus JC Viruria in Chronic Inflammatory Rheumatic Diseases Patients in Treatment with Anti-TNF \u03b1: A 18 Month Follow-Up Study"],"prefix":"10.3389","volume":"7","author":[{"given":"Donatella Maria","family":"Rodio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Anzivino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Mischitelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Bellizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossana","family":"Scrivo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Scribano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianlorenzo","family":"Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Prezioso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Trancassini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Valesini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Teresa","family":"Palamara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Pietropaolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,5,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1099\/0022-1317-82-5-1221","article-title":"Genotypes of JC virus in East, Central and Southwest Europe","volume":"82","author":"Agostini","year":"2001","journal-title":"J. Gen. Virol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"B3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s13365-011-0036-3","article-title":"Polyomavirus JC reactivation and noncoding control region sequence analysis in pediatric Crohn's disease patients treated with infliximab","volume":"17","author":"Bellizzi","year":"2011","journal-title":"J. Neurovirol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/1743-422X-10-298","article-title":"Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study","volume":"30","author":"Bellizzi","year":"2013a","journal-title":"Virol. J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/839719","article-title":"New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy","volume":"2013","author":"Bellizzi","year":"2013b","journal-title":"Clin. Dev. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jbspin.2014.12.010","article-title":"Human polyomavirus JC presence in chronic inflammatory rheumatic diseases patients treated with anti-TNF-\u03b1: evaluation of JC viral loads in urine and plasma samples","volume":"82","author":"Bellizzi","year":"2015","journal-title":"Joint Bone Spine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2165\/11537510-000000000-00000","article-title":"Progressive multifocal leukoencephalopathy and newer biological agents","volume":"33","author":"Berger","year":"2010","journal-title":"Drug Saf."},{"key":"B8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/acr.21564","article-title":"Incidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseases","volume":"64","author":"Bharat","year":"2012","journal-title":"Arthritis Care Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"iv9","DOI":"10.1093\/rheumatology\/kes086","article-title":"Disease control with glucocorticoid therapy in rheumatoid arthritis","volume":"51","author":"Bijlsma","year":"2012","journal-title":"Rheumatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.semarthrit.2015.06.003","article-title":"Considerations on the appropriateness of the John Cunningham virus antibody assay use in patients with rheumatoid arthritis","volume":"45","author":"Borie","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"B11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1365-3083.1991.tb01594.x","article-title":"Separation of leucocytes: improved cell purity by fine adjustments of gradient medium density and osmolality","volume":"34","author":"B\u00f8yum","year":"1991","journal-title":"Scand. J. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/jmv.23525","article-title":"Latent viral infections in young patients with inflammatory diseases treated with biological agents: prevalence of JC virus genotype 2","volume":"5","author":"Comar","year":"2013","journal-title":"J. Med. Virol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cytogfr.2013.12.006","article-title":"Dominance of the strongest: inflammatory cytokines versus glucocorticoids","volume":"25","author":"Dejager","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/13550280802425467","article-title":"JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy","volume":"15","author":"Delbue","year":"2009","journal-title":"J. Neurovirol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1002\/jmv.21313","article-title":"Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individuals","volume":"80","author":"Delbue","year":"2008","journal-title":"J. Med. Virol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/01.NPR.0000461950.23292.18","article-title":"Management of patients with psoriatic arthritis","volume":"40","author":"Dewing","year":"2015","journal-title":"Nurse Pract."},{"key":"B17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1086\/597126","article-title":"Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors","volume":"199","author":"Egli","year":"2009","journal-title":"J. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1128\/CMR.05031-11","article-title":"Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain","volume":"25","author":"Ferenczy","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/0042-6822(91)90069-N","article-title":"Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction","volume":"180","author":"Flaegstad","year":"1991","journal-title":"Virology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.berh.2006.08.007","article-title":"Infection and musculoskeletal conditions: viral causes of arthritis","volume":"20","author":"Franssila","year":"2006","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"B21","first-page":"789","article-title":"The dimensions of health outcomes: the Health Assessment Questionnaire, disability and pain scales","volume":"9","author":"Fries","year":"1982","journal-title":"J. Rheumatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1001\/jamaneurol.2014.63","article-title":"JC Virus in CD34+ and CD19+ cells in patients with multiple sclerosis treated with natalizumab","volume":"71","author":"Frohman","year":"2014","journal-title":"JAMA Neurol."},{"key":"B23","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J. Rheumatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/rheumatology\/kev347","article-title":"RA: from risk factors and pathogenesis to prevention. Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment","volume":"53","author":"Gerlag","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4329\/wjr.v7.i9.236","article-title":"Ankylosing spondylitis: a state of the art factual backbone","volume":"7","author":"Ghasemi-Rad","year":"2015","journal-title":"World J. Radiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13365-012-0078-1","article-title":"Assessment of the risk of polyomavirus JC reactivation in patients with immuno-mediated diseases during long-term treatment with infliximab","volume":"18","author":"Giannecchini","year":"2012","journal-title":"J. Neurovirol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/NRL.0b013e318247b868","article-title":"Progressive multifocal leukoencephalopathy in a patient treated with etanercept","volume":"18","author":"Graff-Radford","year":"2012","journal-title":"Neurologist"},{"key":"B28","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/apm.12128","article-title":"The human JC polyomavirus (JCPyV): virological background and clinical implications","volume":"121","author":"Hirsch","year":"2013","journal-title":"APMIS"},{"key":"B29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1177\/0961203312470977","article-title":"Analysis of JC virus DNA in NPSLE patients treated with different immunomodulatory agents","volume":"22","author":"Iacobaeus","year":"2013","journal-title":"Lupus"},{"key":"B30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1080\/13550280152537102","article-title":"A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region","volume":"7","author":"Jensen","year":"2001","journal-title":"J. Neurovirol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1007\/s007050170023","article-title":"New JC virus (JCV) genotypes from papua new guinea and micronesia (type 8 and type 2E) and evolutionary analysis of 32 complete JCV genomes","volume":"146","author":"Jobes","year":"2001","journal-title":"Arch. Virol."},{"key":"B32","author":"Kelly","year":"2015","journal-title":"Rheumatoid Arthritis: Updated Recommendations Released"},{"key":"B33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/(SICI)1096-9071(199607)49:3<199::AID-JMV7>3.0.CO;2-#","article-title":"Glial and muscle embryonal carcinoma cell specific independent regulation of expression of human JC virus early promoter by cyclic AMP response elements and adjacent nuclear factor 1 binding sites","volume":"49","author":"Kumar","year":"1996","journal-title":"J. Med. Virol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/339237a0","article-title":"Avoiding false positive with PCR","volume":"339","author":"Kwok","year":"1989","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.berh.2015.05.009","article-title":"Risk of infection with biologic antirheumatic therapies in patients with rheumatoid arthritis","volume":"29","author":"Lahiri","year":"2015","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/ibd.20131","article-title":"Infliximab and the risk of latent viruses reactivation in active Crohn's disease","volume":"13","author":"Lavagna","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1741-7015-10-82","article-title":"Gender and the treatment of immunemediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study","volume":"10","author":"Lesuis","year":"2012","journal-title":"BMC Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/infdis\/167.1.13","article-title":"Incidence of BK virus and JC virus viruria in human immunodeficiency virus infected and uninfected subjects","volume":"167","author":"Markowitz","year":"1993","journal-title":"J. Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1099\/vir.0.023184-0","article-title":"Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter\/enhancer of JC virus and supports viral activity","volume":"91","author":"Marshall","year":"2010","journal-title":"J. Gen. Virol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s11481-010-9203-1","article-title":"Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy","volume":"5","author":"Marshall","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1099\/vir.0.035832-0","article-title":"JC virus promoter\/enhancers contain TATA box-associated Spi-B binding sites that support early viral gene expression in primary astrocytes","volume":"93","author":"Marshall","year":"2012","journal-title":"J. Gen. Virol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/13550280701381324","article-title":"Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis","volume":"13","author":"Marzocchetti","year":"2007","journal-title":"J. Neurovirol."},{"key":"B43","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1201\/b13907-15","article-title":"The Human Polyomavirus JC and progressive multifocal leukoencephalopathy","volume-title":"Neuroviral Infections: General Principles and DNA Viruses","author":"Mischitelli","year":"2013"},{"key":"B44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1741-7015-12-43","article-title":"What is the future of targeted therapy in rheumatology: biologics or small molecules?","volume":"12","author":"M\u00f3csai","year":"2014","journal-title":"BMC Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/rheumatology\/12.3.115","article-title":"The pattern of chest and spinal mobility in ankylosing spondylitis: un objective clinical study of 106 patients","volume":"12","author":"Moll","year":"1973","journal-title":"Rheumatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1002\/art.34468","article-title":"Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies","volume":"64","author":"Molloy","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1002\/jcp.24089","article-title":"Reactivation of human polyomavirus JC in patients affected by psoriasis vulgaris and psoriatic arthritis and treated with biological drugs: preliminary results","volume":"227","author":"Nardis","year":"2012","journal-title":"J. Cell Physiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/1756285615602832","article-title":"Progressive Multifocal Leukeoncephalopathy Consortium. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives","volume":"8","author":"Pavlovic","year":"2015","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"B49","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/714044482","article-title":"Rearrangement patterns of JC virus noncoding control region from different biological samples","volume":"9","author":"Pietropaolo","year":"2003","journal-title":"J. Neurovirol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/infdis\/jir256","article-title":"Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients","volume":"204","author":"Reid","year":"2011","journal-title":"J. Infect. Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1136\/jnnp.2009.201079","article-title":"No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18 month follow-up study","volume":"81","author":"Rinaldi","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"B52","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","article-title":"Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis","volume":"9","author":"Tan","year":"2010","journal-title":"Lancet Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis. Development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e82796","DOI":"10.1371\/journal.pone.0082796","article-title":"Risk acceptance in multiple sclerosis patients on natalizumab treatment","volume":"8","author":"Tur","year":"2013","journal-title":"PLoS ONE"},{"key":"B55","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"Van der Linden","year":"1984","journal-title":"Arthritis Rheum."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1136\/gut.2007.145698","article-title":"JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?","volume":"57","author":"Verbeeck","year":"2008","journal-title":"Gut"},{"key":"B57","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00430-015-0390-5","article-title":"Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics","volume":"204","author":"Verheyen","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"key":"B58","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1128\/JVI.64.6.3139-3143.1990","article-title":"Isolation of a possible archetypal JC virus DNA sequence from non-immunocompromised individuals","volume":"64","author":"Yogo","year":"1990","journal-title":"J. Virol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/jmv.23585","article-title":"Molecular epidemiology of JCV genotypes in patients and healthy subjects from Northern Italy","volume":"85","author":"Zanotta","year":"2013","journal-title":"J. Med. Virol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T16:50:30Z","timestamp":1600534230000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmicb.2016.00672\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,10]]},"references-count":59,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2016.00672","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,10]]}}}